Michigan Angel Group Backs Nursing Home Logistics, AI Dominates Q1 Funding, and Why it Takes 500 Site Walks

Happy Thursday.

Here are your angel deals of the week, some bookmarks I think you’ll enjoy, and the best nugget from my conversation with Henry Talamantes, PropTech Growth Expert. 

🔥Angel Deals of the Week

Angel funding rounds announced in recent weeks, compiled from public sources. These deals represent the elite few that survived an angel network’s vetting process. Note: I have not personally analyzed these companies and am sharing for informational purposes only.

🤝 Want more details on these companies or have an angel deal to share? Reply to this email - I’d be happy to connect you with the source angel group or feature your deal.

🤖Deal summaries generated using dealmemo.ai.

HeraWell Technologies, Inc. | Hospital-to-nursing home patient matching

Participating Group: Birmingham Angels

HeraWell Technologies is developing BedConnect, a platform that integrates and replaces hospital and nursing home referral systems to optimize patient discharges to post-acute care facilities. The company's solution matches patients directly to appropriate care sites based on key criteria, replacing the current "scattershot" approach. HeraWell recently secured Seed funding from CitySide Ventures, Birmingham Angels, and other Michigan early-stage investors.

Lindsay A. Joseph | Seed Round | Birmingham, Michigan | March 2025 | Source

EndoShunt Medical | Surgical bleeding control device

Participating Group: Baylor Angel Network

EndoShunt Medical is developing a Class II medical device that provides surgeons with targeted control over abdominal bleeding. The company has secured investment from the Baylor Angel Network to advance this life-saving technology toward market launch. The device aims to address critical needs in surgical procedures where controlling bleeding is essential for patient outcomes.

Tyler Zanon | Seed Round | Chicago, Illinois | April 2025 | Source

Neuranics | Magnetic sensing for human-machine interaction

Participating Group: Archangels

Neuranics, a Scottish deep-tech semiconductor company founded in 2021, has secured $8M in seed funding for its Tunnelling Magnetoresistance sensing technology. The company's ultra-sensitive, low-power sensors detect magnetic signals from the human body without skin contact, enabling precise tracking of muscle activity and heart signals. Currently collaborating with Tier-1 semiconductor and XR manufacturers, Neuranics is targeting applications in XR hardware, wearables, and digital health markets. The funding will strengthen its team and accelerate commercial adoption across consumer, industrial, and healthcare sectors.

Noel McKenna | Seed Round | Glasgow, Scotland | April 2025 | Source

🔖Bookmarks

1. Holy moly. According to PitchBook, AI & ML represented 58% of all VC deal activity value and 28% of deal count in Q1 2025. 🤖 | @PitchBook (link)

2. ICYMI, your weekly tech bro tea: former Rippling employee fesses up to spying for Deel 🕵️‍♂️ | @Reuters (link)

3. Super detailed analysis of how a founder spent 17,784 hours over 5 years building his startup ⏳ | Sam Corcos @Levels c/o 1st Round (link)

🥇The Nugget: My Top Takeaway from This Week’s Conversation with Henry Talamantes

Ridiculous Customer Discovery Is the Way 🔍

The "in" doesn't matter.

What matters is being ready to make the most of that "in."

Example: Henry landed his first enterprise client for Fetch because an exec liked the logo.

But his capacity to close was predicated on a stupid deep understanding of the problem.

To prep for that sale, Henry and his team did over 500 site walks of different buildings.

Five.

Hundred.

Buildings.

By the time he got the shot at a pitch, he knew more about the client's portfolio than they did. He knew which properties had the biggest issues, who the key managers were, and what the real costs were.

Takeaway: Don't build a shiny cool product in a closet and then try to force-feed it to the market. Instead, go do stupid customer discovery, then build the obvious-in-your-face solution people are buying from you before it’s even built.

When evaluating PropTech startups, ask founders:

• How many site visits have you done?

• Can you explain the day-to-day ops challenges better than the executives who would buy this? Can you give me some examples?

• Can you tell me about your relationships with front-line managers and operators?

Want more? Check out my full conversation with Henry 👇

🎙️ Latest Episode

Listen now on Apple Podcasts, Spotify, YouTube, and more.

Until Next Week👋

Thanks for reading - have a great week.

-Andrew

P.S. If you enjoyed this post, could you do me a quick favor? Hit the "like" button or leave a comment with your thoughts. It may not seem like much, but it really helps me out a ton.

If you’re finding this newsletter valuable, share it with a friend, and consider subscribing if you haven’t already. You can also find me on LinkedIn and X.